155 related articles for article (PubMed ID: 3372678)
21. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
[TBL] [Abstract][Full Text] [Related]
22. Osteoblast dysfunction in male idiopathic osteoporosis.
Pernow Y; Granberg B; Sääf M; Weidenhielm L
Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Recker RR; Marin F; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Farrerons J; Sanz B; Oertel H; Stepan J
J Bone Miner Res; 2009 Aug; 24(8):1358-68. PubMed ID: 19338452
[TBL] [Abstract][Full Text] [Related]
24. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
[No Abstract] [Full Text] [Related]
25. Uptake of radioactive 85Sr by the spine in patients with untreated and treated hyperthyroidism.
Anttonen VM; Karjalainen P; Raunio H; Holopainen T
Ann Clin Res; 1973 Aug; 5(4):225-30. PubMed ID: 4771300
[No Abstract] [Full Text] [Related]
26. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
[TBL] [Abstract][Full Text] [Related]
27. Further findings on the inhibitory effect of estradiol benzoate on the circulation and on 45Ca and 3H-proline incorporation in rat bones.
Kapitola J; Andrle J; Kubícková J
Exp Clin Endocrinol; 1992; 100(3):140-4. PubMed ID: 1305065
[TBL] [Abstract][Full Text] [Related]
28. [The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME].
Kapitola J; Andrle J; Haas T; Kubícková J
Sb Lek; 1996; 97(4):455-61. PubMed ID: 9424710
[TBL] [Abstract][Full Text] [Related]
29. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Boivin G; Meunier PJ
Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
[TBL] [Abstract][Full Text] [Related]
30. Bone blood flow after spinal paralysis in the rat.
Takahashi H; Yamamuro T; Okumura H; Kasai R; Tada K
J Orthop Res; 1990 May; 8(3):393-400. PubMed ID: 2324858
[TBL] [Abstract][Full Text] [Related]
31. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis.
Darby AJ; Meunier PJ
Calcif Tissue Int; 1981; 33(3):199-204. PubMed ID: 6791782
[TBL] [Abstract][Full Text] [Related]
32. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
33. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
34. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis.
Brown JP; Delmas PD; Arlot M; Meunier PJ
J Clin Endocrinol Metab; 1987 May; 64(5):954-9. PubMed ID: 3494038
[TBL] [Abstract][Full Text] [Related]
35. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
[TBL] [Abstract][Full Text] [Related]
36. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
[TBL] [Abstract][Full Text] [Related]
37. Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.
Fox J; Miller MA; Recker RR; Bare SP; Smith SY; Moreau I
J Musculoskelet Neuronal Interact; 2005; 5(4):356-7. PubMed ID: 16340137
[No Abstract] [Full Text] [Related]
38. Bone blood flow in the rat using arteriolar blockade: comparisons between labelled resin particles and microspheres.
Revell WJ; Brookes M
J Anat; 1993 Jun; 182 ( Pt 3)(Pt 3):305-12. PubMed ID: 8226285
[TBL] [Abstract][Full Text] [Related]
39. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
40. The relationship of bone blood flow, bone tracer deposition, and endosteal new bone formation.
McInnis JC; Robb RA; Kelly PJ
J Lab Clin Med; 1980 Sep; 96(3):511-22. PubMed ID: 7400674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
